申请人:GlaxoSmithKline Intellectual Property Development
Limited
公开号:EP3148975A1
公开(公告)日:2017-04-05
BISAMIDE SARCOMERE ACTIVATING COMPOUNDS AND USES THEREOF
申请人:Amgen Inc.
公开号:US20220281850A1
公开(公告)日:2022-09-08
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising a compound of the invention, a method for manufacturing compounds of the invention and therapeutic uses thereof.